evaluation of virtual reality exposure therapy for patients with pain disorders
Not Applicable
Recruiting
- Conditions
- cancer pain and chronic pain
- Registration Number
- JPRN-UMIN000050785
- Lead Sponsor
- Hirosaki University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
patients who have low performance status
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effect on subjective age, depression, and cognitive function
- Secondary Outcome Measures
Name Time Method
Related Trials
Completed
Johnson & Johnson Pharmaceutical
Updated 5/13/2024
Phase 1
Janssen-Cilag International N.V.
Updated 3/13/2017
Janssen-Cilag International N.V.
Updated 3/19/2012
Janssen-Cilag International N.V.
Updated 3/19/2012
Janssen-Cilag International N.V.
Updated 3/19/2012
Phase 1
Janssen-Cilag International N.V.
Updated 10/8/2021
Phase 1
Janssen-Cilag International N.V.
Updated 8/21/2017
Janssen-Cilag International N.V.
Updated 3/19/2012
Janssen-Cilag International N.V.
Updated 3/19/2012